Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

BACKGROUND: Response rates are primary endpoints in many oncology trials; however, correlation with overall survival (OS) is not uniform across cancer types, treatments, or lines of therapy. This study explored the association between objective response (OR) and OS in patients with chemotherapy-refr...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447510/
https://www.ncbi.nlm.nih.gov/pubmed/30721341
http://dx.doi.org/10.1007/s00262-018-02295-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447510/
https://www.ncbi.nlm.nih.gov/pubmed/30721341
http://dx.doi.org/10.1007/s00262-018-02295-4

Ejemplares similares